Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab: Editorial comment
Year: 2011
Type: article
Source: The Journal of Urology
Author: Samir S. Taneja
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2991385593